Celebrating our 10th anniversary – Unlock our special offer today

Swedish pharma regulator granted control over e-cigs

Swedish flag grunge 300x180A Swedish court has upheld attempts by the country’s medical products regulator to treat nicotine-containing e-cigarettes as pharmaceuticals, meaning that they must go through a licensing process and cannot be sold in outlets such as groceries and convenience stores.

The regulator, the Läkemedelsverket, last October tried to stop a retailer selling e-cigs on the basis that they have “pharmacological effect and medical use” and are therefore covered by the Medicines Act.

The retailer appealed that prohibition, and sales were allowed to continue while the court considered the case. It has now ruled in favour of the Läkemedelsverket.

“We believe that e-cigs are a great way to stop smoking but an approved product has to be developed first,” the agency’s nicotine specialist Martin Burman was quoted as saying. “Those sold today are neither proven, safe nor effective.”

The regulator would focus on controlling imports, Burman suggested, adding that “municipalities are able to conduct oversight of sales in small shops”.

Subscribe to our Newsletter

Join in to hear about news, events, and podcasts in the sector

    See more

    Swedish customs has also had e-cigarettes in its sights, citing Läkemedelsverket rules to support the seizure of shipments of liquid nicotine which did not have a permit.

    What This Means: The sale of e-cigarette hardware and nicotine-free liquid has been uncontested in Sweden, but as in many countries the legal position of nicotine-containing e-liquid has been somewhat hazy.

    This latest ruling – which avoids the common and dubious question of whether e-cigs are tobacco products, and addresses instead whether they can be considered as medical products – appears to clarify that, for now. But it remains to be seen whether the issue will come back to court.

    – Barnaby Page ECigIntelligence staff

    Photo: Nicolas Raymond

    Barnaby Page

    Editorial director
    Before joining ECigIntelligence in early 2014 as one of its first employees, Barnaby had a 30-year career as a reporter and editor for newspapers, magazines and online services, working in Canada, the US and the Middle East as well as his current British location. He has edited publications covering fields including technology and the advertising industry, and was launch editor of the first large daily online news service in the British regional media. Barnaby also writes on classical music and film for a number of publications. Barnaby manages the editorial and reporting teams and works closely with the analyst teams, to ensure that all content meets high standards of quality and relevance. He also writes for the site occasionally, mostly on science-related issues, and is a member of the Association of British Science Writers.

    Our Key Benefits

    The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

    ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

    • Stay informed of any legal and market change in the sector that impacts your organisation
    • Maximise resources by getting market and legal data analysis daily in one place
    • Make smart decisions by understanding how the regulatory and market landscape evolves
    • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization